SEATTLE, Sept. 27, 2012 /PRNewswire/ – Omeros Corporation (OMER) today announced that its Board of Directors has elected Arnold C. Hanish to serve on the Company’s Board. Mr. Hanish has also been appointed to serve as Chairman of the Audit Committee.
“Arnie’s substantial depth and breadth of financial experience in the pharmaceutical industry will serve Omeros well as we advance our products to commercialization,” stated Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. “We are pleased to add Arnie to our Board and expect that he will prove to be a valuable addition to our team.”
“I am impressed with Omeros’ collection of late- and early-stage programs and its ability to drive the development of this deep pipeline through efficient use of capital,” stated Arnold C. Hanish. “I look forward to working with management to capitalize on Omeros’ multiple opportunities for success.”
Mr. Hanish has over 40 years of experience in finance. He currently serves as vice president, chief accounting officer, at Eli Lilly and Company, a position he has held since 1994. Prior to his appointment as chief accounting officer, he held a number of senior financial positions at Eli Lilly. Before Eli Lilly, Mr. Hanish was with Arthur Young & Company (currently Ernst & Young) for nearly 14 years. Mr. Hanish is a member of the Standing Advisory Group of the Public Company Accounting Oversight Board (PCAOB). In addition, he is the immediate past chairperson of Financial Executives International’s (FEI’s) Committee on Corporate Reporting, a position he held from 2007 to 2010. Mr. Hanish earned his B.A. in accounting from the University of Cincinnati.